Entry |
|
Name |
Secobarbital (USP/INN); Seconal (TN) |
Formula |
C12H18N2O3
|
Exact mass |
238.1317
|
Mol weight |
238.28
|
Structure |

|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01837 Barbiturate sedative-hypnotics
DG01567 GABA-A receptor agonist
|
Remark |
|
Efficacy |
Sedative-hypnotic |
Comment |
Barbiturates
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
map07230 | GABA-A receptor agonists/antagonists |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CA Barbiturates, plain
N05CA06 Secobarbital
D00430 Secobarbital (USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01837 Barbiturate sedative-hypnotics
DG00917 Secobarbital
D00430 Secobarbital
DG01567 GABA-A receptor agonist
DG00917 Secobarbital
D00430 Secobarbital
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D00430 Secobarbital (USP/INN)
Narcotics and psychotropics in Japan [br08308.html]
Psychotropics by Cabinet order Article 3 (78 substances)
D00430
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01837 Barbiturate sedative-hypnotics
DG00917 Secobarbital
DG01567 GABA-A receptor agonist
DG00917 Secobarbital
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 17
1 C1z C 25.4856 -18.1010
2 C5x C 25.4856 -19.5018
3 C5x C 24.2717 -17.4006
4 C1c C 26.8747 -18.1010
5 C1b C 25.4799 -16.7060
6 N1x N 24.2717 -20.2079
7 O5x O 26.6997 -20.2079
8 N1x N 23.0519 -18.1010
9 O5x O 24.2717 -15.9998
10 C1b C 27.5634 -16.8928
11 C1a C 27.5751 -19.3149
12 C2b C 26.6938 -16.0056
13 C5x C 23.0519 -19.5018
14 C1b C 28.9642 -16.8928
15 C2a C 26.6938 -14.6108
16 O5x O 21.8380 -20.2079
17 C1a C 29.6587 -15.6847
BOND 17
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 2 7 2
7 3 8 1
8 3 9 2
9 4 10 1
10 4 11 1
11 5 12 1
12 6 13 1
13 10 14 1
14 12 15 2
15 13 16 2
16 14 17 1
17 8 13 1
|